AssetMark Inc’s Bio-Techne TECH Stock Holding History

AssetMark Inc’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10K	Sell	142 -998	-88%	-$53.9K	﹤0.01%	2448
2026 Q1	$59.6K	Sell	1,140 -399	-26%	-$23.9K	﹤0.01%	1692
2025 Q4	$90.5K	Buy	1,539 +3	+0.2%	+$182	﹤0.01%	1528
2025 Q3	$85.5K	Buy	1,536 +135	+10%	+$7.23K	﹤0.01%	1482
2025 Q2	$72.1K	Buy	1,401 +1,286	+1,118%	+$64.6K	﹤0.01%	1443
2025 Q1	$6.74K	Sell	115 -129	-53%	-$8.74K	﹤0.01%	1926
2024 Q4	$17.6K	Buy	244 +174	+249%	+$12.8K	﹤0.01%	1686
2024 Q3	$5.59K	Sell	70 -30	-30%	-$2.25K	﹤0.01%	1718
2024 Q2	$7.17K	Buy	+100	New	+$7.36K	﹤0.01%	1552
2024 Q1	–	Sell	-10	Closed	-$772	–	2113
2023 Q4	$772	Buy	+10	New	+$659	﹤0.01%	1648
2022 Q1	–	Sell	-8	Closed	-$1K	–	1741
2021 Q4	$1K	Hold	8	–	–	﹤0.01%	1473
2021 Q3	$1K	Buy	+8	New	+$974	﹤0.01%	1358
2021 Q2	–	Sell	-8	Closed	-$1K	–	1534
2021 Q1	$1K	Buy	+8	New	+$730	﹤0.01%	1298
2018 Q1	–	Sell	-28	Closed	-$1K	–	1960
2017 Q4	$1K	Buy	+28	New	+$890	﹤0.01%	1717
2017 Q1	–	Sell	-8	Closed	–	–	1436
2016 Q4	$0	Buy	+8	New	+$210	﹤0.01%	1390

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AssetMark Inc's TECH Position: Q2 2026 in Review

AssetMark Inc reduced its Bio-Techne (TECH) stake by 88% in Q2 2026, selling an estimated $53.9K and leaving 142 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #2448.

AssetMark Inc first reported a position in TECH in Q4 2016 and has held it in 15 quarters since. The position peaked at $90.5K in Q4 2025. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

AssetMark Inc held 142 shares of Bio-Techne worth $10K as of Q2 2026.
AssetMark Inc sold 998 Bio-Techne shares in Q2 2026, an estimated $53.9K.
Bio-Techne made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #2448 holding.
AssetMark Inc first reported a position in Bio-Techne in Q4 2016 and has held it in 15 quarters since.
AssetMark Inc's Bio-Techne position peaked at $90.5K in Q4 2025.
595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.